• 2026-05-18 08:35:33
  Astral interim results March 2026

  Revenue for the period increased by 11.4% to R11.9 billion (R10.7 billion), bringing gross profit up by 82.0% to R2.8 billion (R1.6 billion). Profit before interest and tax was 347.8% higher at R1.2 billion (R271.0 million). Profit for the period attributable to equity holders of the Company shot up 392.6% to R895.5 million (R181.8 million). In addition, headline earnings per share climbed 466.7% to 2 318 cents per share (409 cents per share). Dividend declaration The board approved an interim dividend of 1 160 cents per ordinary share (gross) in respect of the six months ended 31 March 2026. Company outlook The following factors are considered by management to have a bearing on the near future business and poultry sector prospects: `Bird flu remains a risk to the local poultry industry, particularly with higher infection rates in the Northern Hemisphere during their past winter season. `The Iranian conflict and the surge in oil prices have translated into higher fuel and transport costs, placing additional pressure on consumer disposable income amidst rising unemployment. `Spike in fuel prices and fertilizer costs are expected to weigh heavy on primary agriculture, and could negatively impact local crop production. `El Niño weather phenomenon and a likely drought in the 2026/2027 summer growing season, could impact South Africa’s crops over the coming year. `The uncertain global landscape with heightened geopolitical tensions could lead to an economic slowdown, accompanied by currency and soft commodity volatility. `South Africa is set for a record grain and oilseed harvest for the 2025/2026 season, and this should lead to stable poultry feed input costs over the short term. `Astral’s broiler production volumes envisaged to remain at maximum available capacity to support our best cost producer strategy. `Astral’s bird flu vaccination programme has made good progress, and will provide protection to some of our breeding stock this coming winter season. `Astral’s healthy balance sheet will continue to support key strategic investments, with expansion of manufacturing capabilities and growth opportunities. `Poultry Sector Master Plan (Phase 2) signed which will support local production, uphold current import trade measures and create export opportunities.
• 2026-04-29 07:15:11
  Astral - further trading statement

  Astral issued a further trading statement indicating a significant increase in its financial results for the six months ending 31 March 2026. Shareholders can expect earnings per share (EPS) to rise by approximately 375% to 395%, reaching between 2 242 and 2 336 cents per share, compared to 472 cents in the prior period. Headline earnings per share (HEPS) are projected to increase by 450% to 470%, amounting to between 2 250 and 2 331 cents per share, up from 409 cents. These estimates are unaudited and subject to change. The full results are anticipated to be published on or around 18 May 2026.
• 2026-03-18 07:35:23
  Astral - trading statement

  Astral has announced that for the six months ending 31 March 2026: •headline earnings per share (HEPS) is expected to increase by at least 435%, resulting in a HEPS of at least R21.88 (HY2025: HEPS of R4.09); and •earnings per share (EPS) is expected to increase by at least 365%, resulting in an EPS of at least R21.95 (HY2025: R4.72).
• 2026-03-10 12:15:00
  Astral Foods Ltd. - Executive Director's Dealings

  A director has dealt in shares of the company.
• 2026-03-02 15:19:10
  Astral - appointment of CFO

  Shareholders are referred to the announcement regarding the appointment of Gideon Johannes (Johan) Geel as an Executive Director and the Chief Financial Officer of Astral with effect from 1 March 2026. With reference to paragraph 6.74 of the JSE Requirements and the integrity information contained in Schedule 1, the Company confirms that there were no positive statements made by Mr Johan Geel.

No financial data available.